David Venables

David Venables

Chief Executive Officer at
Synpromics Ltd.
Health Technology
Commercial Services
Consumer Services

Profile

Dr. David C.
Venables is a Chief Executive Officer & Director at Laverock Therapeutics Ltd. and a Chief Executive Officer at Synpromics Ltd. He is on the Board of Directors at Laverock Therapeutics Ltd. Dr. Venables was previously employed as a Chief Executive Officer, Director & MD by Anatara Lifesciences Ltd., a Non-Executive Director by Ark Therapeutics Group Plc, a Chief Operating Officer by Intercell USA, Inc., a Head-Process Development by Medeva Plc, and an Operations Director by Q-One Biotech Ltd. He received his doctorate degree from the University of Surrey.

David Venables active positions

CompaniesPositionStart
Chief Executive Officer -
Chief Executive Officer 01/08/2021

Former positions of David Venables

CompaniesPositionEnd
Director/Board Member 27/02/2015
ANATARA LIFESCIENCES LTD Chief Executive Officer 24/02/2015
Corporate Officer/Principal -
Corporate Officer/Principal -
IOMAI CORPORATION Chief Operating Officer -
See the detail of David Venables's experience

Training of David Venables

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Process Industries

Commercial Services

  1. Stock Market
  2. Insiders
  3. David Venables